Newsletter
Signup
Login
Welcome Guest
Enter Company

Reckitt to pay $1.4 billion to end U.S. opioid addiction treatment probes

Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals business Indivior before it was spun out of the company carried out an illegal scheme to boost sales of an opioid addiction treatment.
Thu, 11 Jul 2019 14:10:26 -0400

Related News Articles

Loading...

Market blog




Advetisement



Opinion Poll